Imagine if getting a gynecological check-up was as simple as using a tampon at home. Instead of a stressful clinic visit with uncomfortable tools, you collect a sample yourself and send it off. A smart app then analyzes your microbiome to spot infections or cancer risks and suggests a personalized care plan.
Women face significant barriers to gynecological screenings due to clinic scheduling, fear, and discomfort with speculum exams, leading to late detection of STIs and cervical cancer.
A diagnostic tampon for home sample collection and a digital platform for diagnosis, risk evaluation, and aftercare management.
If you are a FemTech startup dealing with low patient engagement in preventative screenings — this project developed a diagnostic tampon that allows users to collect samples at home for HPV and STI testing, increasing participation through comfort.
If you are a diagnostic laboratory dealing with low-quality samples from traditional swabs — this project developed a proprietary DNA extraction protocol for PCR analysis that tests for 16 different factors at once for higher accuracy.
If you are a telemedicine platform dealing with fragmented aftercare for women's health — this project developed a digital layer that provides diagnosis, risk evaluation, and integrated aftercare like prescriptions and consultations.
Based on available project data, the specific price for the end-user or the cost per test is not mentioned.
Yes, one of the project's core objectives is to set up manufacturing and launch the screening service to scale the commercialization.
The company has patented a proprietary protocol for DNA extraction from a tampon for PCR analysis, enabling the testing of 16 different factors simultaneously.
The service includes a digital layer for diagnosis and aftercare, which allows for booking in-person visits and providing prescriptions.
The project period runs from 2023-07-01 to 2025-06-30, indicating the scale-up phase is currently active.
The project is led by a single Bulgarian SME, Tampon Innovations (Daye), which holds 100% of the industry ratio. While the consortium is small in terms of formal partners, the company is leveraging strategic external collaborations with the University of Edinburgh, the Scottish HPV Reference Laboratory, and Hologic for clinical validation.
Contact Tampon Innovations OOD (Daye) in Bulgaria
Contact us to explore licensing opportunities for the patented DNA extraction protocol.
